[{"address1": "11 Commerce Drive", "address2": "First Floor", "city": "Cranford", "state": "NJ", "zip": "07016", "country": "United States", "phone": "908 967 6677", "website": "https://citiuspharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Citius Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of critical care products. Its LYMPHIR, an FDA approved product, is a targeted immunotherapy for the treatment of cutaneous T-cell lymphoma. The company's late-stage pipeline includes Mino-Lok, an antibiotic lock solution to salvage catheters in patients with catheter-related bloodstream infections; and CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids. The Pivotal Phase 3 Trial for Mino-Lok and a Phase 2b trial for Halo-Lido completed. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey.", "fullTimeEmployees": 23, "companyOfficers": [{"maxAge": 1, "name": "Mr. Leonard L. Mazur", "age": 79, "title": "Co-Founder, CEO, Chairman & Secretary", "yearBorn": 1945, "fiscalYear": 2024, "totalPay": 688750, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Myron Z. Holubiak", "age": 77, "title": "Co-Founder & Executive Vice Chairman", "yearBorn": 1947, "fiscalYear": 2024, "totalPay": 652500, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jaime  Bartushak", "age": 56, "title": "Chief Business Officer & CFO", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 589026, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Gary F. Talarico", "age": 69, "title": "Executive Vice President of Operations", "yearBorn": 1955, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Ilanit  Allen", "title": "Vice President of Investor Relations & Corporate Communications", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Alan  Lader Ph.D.", "title": "Senior VP and Head of Clinical Operations & Quality Assurance", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Myron S. Czuczman M.D.", "age": 64, "title": "Executive VP & Chief Medical Officer", "yearBorn": 1960, "fiscalYear": 2024, "totalPay": 571375, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Dhananjay G. Wadekar", "age": 70, "title": "Senior Vice President of Business Strategy", "yearBorn": 1954, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Kelly  Creighton Ph.D.", "title": "Executive Vice President of Chemistry, Manufacturing & Controls", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Nikolas  Burlew", "title": "Executive Vice President of Quality Assurance", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.29, "open": 1.28, "dayLow": 1.21, "dayHigh": 1.3129, "regularMarketPreviousClose": 1.29, "regularMarketOpen": 1.28, "regularMarketDayLow": 1.21, "regularMarketDayHigh": 1.3129, "payoutRatio": 0.0, "beta": 1.188, "forwardPE": 6.4736843, "volume": 250344, "regularMarketVolume": 250344, "averageVolume": 2681413, "averageVolume10days": 287300, "averageDailyVolume10Day": 287300, "bid": 1.2, "ask": 1.26, "bidSize": 1, "askSize": 3, "marketCap": 13744635, "fiftyTwoWeekLow": 0.65, "fiftyTwoWeekHigh": 20.0, "fiftyDayAverage": 1.33096, "twoHundredDayAverage": 2.710385, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 16478877, "profitMargins": 0.0, "floatShares": 9595634, "sharesOutstanding": 10830300, "sharesShort": 1121886, "sharesShortPriorMonth": 1348420, "sharesShortPreviousMonthDate": 1749772800, "dateShortInterest": 1752537600, "sharesPercentSharesOut": 0.1004, "heldPercentInsiders": 0.044109996, "heldPercentInstitutions": 0.0733, "shortRatio": 0.54, "shortPercentOfFloat": 0.105, "impliedSharesOutstanding": 11174500, "bookValue": 6.924, "priceToBook": 0.17764299, "lastFiscalYearEnd": 1727654400, "nextFiscalYearEnd": 1759190400, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -43095564, "trailingEps": -5.76, "forwardEps": 0.19, "lastSplitFactor": "1:25", "lastSplitDate": 1732579200, "enterpriseToEbitda": -0.383, "52WeekChange": -0.92532563, "SandP52WeekChange": 0.19554341, "quoteType": "EQUITY", "currentPrice": 1.23, "targetHighPrice": 6.0, "targetLowPrice": 6.0, "targetMeanPrice": 6.0, "targetMedianPrice": 6.0, "recommendationKey": "none", "numberOfAnalystOpinions": 1, "totalCash": 26410, "totalCashPerShare": 0.003, "ebitda": -42983960, "totalDebt": 931795, "quickRatio": 0.001, "currentRatio": 0.368, "debtToEquity": 1.466, "returnOnAssets": -0.25322, "returnOnEquity": -0.6053, "freeCashflow": 15845529, "operatingCashflow": -23545382, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "CTXR", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketTime": 1754683200, "exchange": "NCM", "messageBoardId": "finmb_272471835", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -4.65116, "regularMarketPrice": 1.23, "longName": "Citius Pharmaceuticals, Inc.", "shortName": "Citius Pharmaceuticals, Inc.", "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1754692601, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1412256600000, "postMarketChangePercent": 1.62601, "postMarketPrice": 1.25, "postMarketChange": 0.02, "regularMarketChange": -0.0599999, "regularMarketDayRange": "1.21 - 1.3129", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 2681413, "fiftyTwoWeekLowChange": 0.58000004, "fiftyTwoWeekLowChangePercent": 0.8923078, "fiftyTwoWeekRange": "0.65 - 20.0", "fiftyTwoWeekHighChange": -18.77, "fiftyTwoWeekHighChangePercent": -0.93850005, "fiftyTwoWeekChangePercent": -92.53256, "dividendDate": 1496966400, "earningsTimestamp": 1747254606, "earningsTimestampStart": 1755028800, "earningsTimestampEnd": 1755028800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -5.76, "epsForward": 0.19, "epsCurrentYear": 1.3, "priceEpsCurrentYear": 0.9461539, "fiftyDayAverageChange": -0.100960016, "fiftyDayAverageChangePercent": -0.07585503, "twoHundredDayAverageChange": -1.4803851, "twoHundredDayAverageChangePercent": -0.54618996, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "displayName": "Citius Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-08-09"}]